Patent US4968602A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4968602A Expired / Lapsed US ⏱️ 0.0 years remaining

Solution-phase single hybridization assay for detecting polynucleotide sequences

Assignee: Molecular Diagnostics Inc
•
Filing: 1989-11-21
•
Granted: 1990-11-06
•
Expires: 2009-11-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A process for determining the presence of a particular nucleic acid sequence in a test sample comprising (a) chemically modifying nucleic acids in the test sample either to introduce a label or a reactive site in a manner that supports their hybridizability, (b) contacting under hybridization conditions the chemically modified sample nucleic acids with a hybridizable nucleic acid probe which either, when the sample nucleic acids have been modified to introduce a label, carrys a reactive site or, when the sample nucleic acids have been modified to introduce a reactive site, is labeled, (c) contacting the solution resulting from step (b) with a immobilized form of a reactive partner to the reactive site to form a stable bond with the reactive site on the sample nucleic acids or the probe, respectively, (d) separating the resulting immobilized fraction from the remaining solution, and (e) determining the presence of the label in the separated immobilized fraction or a decrease in the label in the remaining solution.

Inventors

  • 👤 Nanibhushan Dattagupta

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 23:55
CPC Classifications
C; C07; C07H; C07H21/00; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; Y; Y10; Y10S; Y10S435/00; Y10S435/803

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 200 words
A process for determining the presence of a particular nucleic acid sequence in a sample containing cells comprising (a) chemically modifying nucleic acids in an unpurified sample, said sample consisting essentially of whole cells, said whole cells being lysed during the process, cell lysates and mixtures thereof, either to introduce a label or a reactive site, wherein the chemical modification of the sample nucleic acids to introduce said label or said reactive site is accomplished by reaction with a photochemical reagent comprising said label or reactive site, respectively, (b) conducting hybridization, (c) contacting under hybridization conditions the chemically modified sample nucleic acids with a hybridizable nucleic acid probe which either, when the sample nucleic acids have been modified to introduce a label, includes a reactive site, or when the sample nucleic acids have been modified to introduce a reactive site, is labeled, (d) contacting the solution resulting from step (c) with an immobilized form of a reactive site on the sample nucleic acids or the probe, respectively, (e) separating the resulting immobilized fraction from the remaining solution, and (f) determining the presence of the label in the separated immobilized fraction or a decrease in the label in the remaining solution.
Claim 2
Dependent Claim 200 words
A process for determining the presence of a particular nucleic acid sequence in a sample containing cells comprising (a) chemically modifying nucleic acids in an unpurified sample, said sample consisting essentially of whole cells, said whole cells being lysed during the process, cell lysates and mixtures thereof, either to introduce a label or a reactive site, wherein the chemical modification of the sample nucleic acids to introduce said label or said reactive site is accomplished by reaction with a photochemical reagent comprising said label or reactive site, respectively, (b) conducting hybridization, (c) contacting under hybridization conditions the chemically modified sample nucleic acids with a hybridizable nucleic acid probe which either, when the sample nucleic acids have been modified to introduce a label, includes a reactive site, or when the sample nucleic acids have been modified to introduce a reactive site, is labeled, (d) contacting the solution resulting from step (c) with an immobilized form of a reactive site on the sample nucleic acids or the probe, respectively, (e) separating the resulting immobilized fraction from the remaining solution, and (f) determining the presence of the label in the separated immobilized fraction or a decrease in the label in the remaining solution.
Claim 3
Dependent Claim 17 words
A process according to claim 1, wherein said photochemically reactive reagent is a nucleic acid binding ligand.
Claim 4
Dependent Claim 25 words
A process according to claim 1, wherein the immobilized form of the reactive partner comprises a solid support to which the reactive group is attached.
Claim 5
Dependent Claim 19 words
A process according to claim 1, wherein the reactive site is a binding site capable of specific noncovalent binding.
Claim 6
Dependent Claim 33 words
A process according to claim 4, wherein the binding site is biotin or a hapten and wherein the immobilized reactive partner is an immobilized form of avidin or an anti-hapten antibody reagent, respectively.
Claim 7
Dependent Claim 33 words
A process according to claim 1, wherein the label is selected from the group consisting of an enzymatically active group, a fluorescer, a chromophore, a luminescer, a specifically bindable ligand and a radioisotope.
Claim 8
Dependent Claim 27 words
A process according to claim 1, wherein the label is a specifically bindable ligand and its presence is determined by binding with a labeled binding partner therefor.
Claim 9
Dependent Claim 27 words
A process according to claim 7, wherein the ligand is biotin or a hapten and the binding partner therefor is avidin or an anti-hapten antibody reagent, respectively.
Claim 10
Dependent Claim 24 words
A process according to claim 1, wherein the particular sequence of interest is characteristic of the presence or absence of a particular genetic disorder.
Claim 11
Dependent Claim 14 words
A process according to claim 9, wherein the genetic disorder is sickle cell anemia.
Claim 12
Dependent Claim 42 words
A process according to claim 1, wherein the test sample nucleic acids are chemically modified to introduce a label in step (a) and the resulting labeled sample nucleic acids are contacted in step (b) with a probe that carries a reactive site.
Claim 13
Dependent Claim 40 words
A process according to claim 1, wherein the test sample nucleic acids are chemically modified to introduce a reactive site in step (a) and the resulting reactive site-modified sample nucleic acids are contacted in step (b) with a labeled probe.
Claim 14
Dependent Claim 20 words
A process according to claim 1, wherein the probe has a concentration that is greater than that of the sample.
Claim 15
Dependent Claim 23 words
A process according to claim 13, wherein the concentration of the probe is in excess of the sample by at least 1,000 times.
Claim 16
Dependent Claim 11 words
A process according to claim 1, wherein the cells are lysed.

References Cited (Backward Citations)

EP0070685A2 Cited
EP0070687B1 Cited
WO1983001459A1 Cited
US4737454A Cited
US4724202A Cited
US4563417A Cited
US4743535A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-11-05 1994-05-07 1994-11-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-11-05 1998-05-07 1998-11-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-11-05 2002-05-07 2002-11-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag